Cell treatment and lysis in 96-well filter-bottom plates for screening Bcr-Abl activity and inhibition in whole-cell extracts Journal Article


Authors: Mand, M. R.; Wu, D.; Veach, D. R.; Kron, S. J.
Article Title: Cell treatment and lysis in 96-well filter-bottom plates for screening Bcr-Abl activity and inhibition in whole-cell extracts
Abstract: Although conventional high-throughput screens performed in vitro with purified protein kinases are powerful tools to discover new kinase inhibitors, they are far from ideal for determining efficacy in vivo. As a complementary approach, cell-based, targetdriven secondary screens may help predict in vivo compound potency and specificity as well as evaluate bioavailability and toxicity. Here the authors report a simple protocol for treating K562 Bcr-Abl-expressing cells with small-molecule kinase inhibitors in 96-well filter-bottom plates followed by in-plate cell lysis. The lysates were assayed via a solid-phase kinase assay, allowing determination of apparent IC 50 for known Bcr-Abl inhibitors as well as facilitating the screening of a small kinase inhibitor library. This approach may have further applications in generating lysates for analyzing kinase activity and inhibition in other nonadherent suspension cell lines. © 2010 Society for Biomolecular Sciences.
Keywords: controlled study; protein expression; unclassified drug; drug targeting; sensitivity and specificity; reproducibility of results; imatinib; enzyme inhibition; models, biological; protein kinase inhibitor; culture medium; drug potency; high throughput screening; drug screening; dose-response relationship, drug; small molecule libraries; 6 (2,6 dichlorophenyl) 2 [3 (hydroxymethyl)anilino] 8 methylpyrido[2,3 d]pyrimidin 7(8h) one; dasatinib; pyrimidines; prediction; protein kinase inhibitors; cell fractionation; cytolysis; bcr abl protein; piperazines; ic 50; inhibitory concentration 50; suspension cell culture; enzyme assay; fusion proteins, bcr-abl; cell extracts; bcr-abl; 6 (2,6 dichlorophenyl) 2 (4 fluoro 3 methylanilino) 8 methyl 8h pyrido[2,3 d]pyrimidin 7 one; 6 (2,6 dichlorophenyl) 8 methyl 2 (3 methylthioanilino) 8h pyrido[2,3 d]pyrimidin 7 one; pd 173952; k562 cells; cell lysis; lead identification; secondary assay; dv 1 10; dv 2 271; dv 2 273; dv 2 281; dv 2 289; dv 2 37; dv 2 43; dv 2 47; dv 2 89; dv 3 081; dv 3 096; dv 5 31; cell strain k 562
Journal Title: Journal of Biomolecular Screening
Volume: 15
Issue: 4
ISSN: 1087-0571
Publisher: Sage Publications  
Date Published: 2010-04-01
Start Page: 434
End Page: 440
Language: English
DOI: 10.1177/1087057110363307
PUBMED: 20237206
PROVIDER: scopus
PMCID: PMC4471859
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "CODEN: JBISF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Darren Veach
    98 Veach